comparemela.com

Magdih Yacoub News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New heart treatment could help the body grow a replacement valve

New heart treatment could help the body grow a replacement valve
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Ross Procedure Offers Excellent Survival 25 Years Out

Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR

Claritas Completes Acquisition of Exclusive Worldwide Rights to Develop and Commercialize R-107 for Pulmonary Disease

Claritas Announces Letter of Intent to Acquire Exclusive Worldwide Rights to Develop R-107 for PAH

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Claritas Announces Letter of Intent to Acquire Exclusive Worldwide Rights to Develop R-107 for PAH Claritas Pharmaceuticals, Inc.April 14, 2021 GMT SAN FRANCISCO and TORONTO, April 14, 2021 (GLOBE NEWSWIRE) Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the “Company” or “Claritas”) today announced that it has entered into a binding Letter of Intent (the “LOI”) with Salzman Group, Inc. (a Delaware corporation), Salzman Group, Ltd. (an Israeli corporation), and Salzman Group Pty. Ltd. (an Australian corporation), (collectively, the “Salzman Group”), under which Salzman Group will grant to Claritas an exclusive, worldwide license to develop and commercialize R-107 for the treatment of pulmonary arterial hypertension (“PAH”). The Company expects that definitive agreements will be executed by May 15, 2021. Closing of the transaction is subject to rece

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.